Interestingly, EVs released by lung cancer cells during radiation therapy increase levels of miR-23a, which mediates a decrease in tumor suppressor PTEN; it is well known that PTEN takes part in the PI3K/Akt pathway, which prevents cell proliferation and suppresses vascular formation. Here, PTEN is linked to neoplasm.